Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107761103 | 10776110 | 3 | F | 20150130 | 20160906 | 20150209 | 20160912 | EXP | US-PFIZER INC-2015048073 | PFIZER | 56.00 | YR | F | Y | 74.00000 | KG | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107761103 | 10776110 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG, 1X/DAY | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 107761103 | 10776110 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 21992 | PROLONGED-RELEASE TABLET | |||||||||||
| 107761103 | 10776110 | 3 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 21992 | PROLONGED-RELEASE TABLET | |||||||||||
| 107761103 | 10776110 | 4 | C | KLONOPIN | CLONAZEPAM | 1 | 0.25 MG (HALF OF 0.5MG TABLET), UNK | 0 | .25 | MG | TABLET | ||||||||
| 107761103 | 10776110 | 5 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107761103 | 10776110 | 1 | Major depression |
| 107761103 | 10776110 | 2 | Post-traumatic stress disorder |
| 107761103 | 10776110 | 3 | Dissociative identity disorder |
| 107761103 | 10776110 | 4 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107761103 | 10776110 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107761103 | 10776110 | Aggression | |
| 107761103 | 10776110 | Agitation | |
| 107761103 | 10776110 | Arthralgia | |
| 107761103 | 10776110 | Balance disorder | |
| 107761103 | 10776110 | Bradyphrenia | |
| 107761103 | 10776110 | Crying | |
| 107761103 | 10776110 | Decreased appetite | |
| 107761103 | 10776110 | Disease progression | |
| 107761103 | 10776110 | Disease recurrence | |
| 107761103 | 10776110 | Headache | |
| 107761103 | 10776110 | Hostility | |
| 107761103 | 10776110 | Hypoglycaemia | |
| 107761103 | 10776110 | Impulsive behaviour | |
| 107761103 | 10776110 | Insomnia | |
| 107761103 | 10776110 | Irritability | |
| 107761103 | 10776110 | Major depression | |
| 107761103 | 10776110 | Nasopharyngitis | |
| 107761103 | 10776110 | Nausea | |
| 107761103 | 10776110 | Restlessness | |
| 107761103 | 10776110 | Suicidal ideation | |
| 107761103 | 10776110 | Thinking abnormal | |
| 107761103 | 10776110 | Vertigo | |
| 107761103 | 10776110 | Visual impairment | |
| 107761103 | 10776110 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107761103 | 10776110 | 1 | 20150130 | 0 |